AH
Andreessen Horowitz (a16z) Bio + Health
Andreessen Horowitz (a16z) Bio + Health is a Series A to growth stage investment firm. It has made 6 investments. They made 1 investments in the last 12 months. Average disclosed round size is $155.1M (across 7 rounds with reported amounts).
Portfolio
6
Fund Size
—
Top Stage
Unknown
Last 12 Mo
1
Team
JC
Jorge Conde
General Partner
JY
Julie Yoo
General Partner
VA
Vineeta Agarwala
General Partner
Portfolio Breakdown
Stage Distribution
Investment Activity
DealsAvg Round Size
Portfolio
7 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| CCartography | Series B | $67M | Oct 2025 |
| FFreenome | Unknown | $330M | Jan 2025 |
| FFreenome | Growth | $254M | Feb 2024 |
| AApeel Sciences | Series D | $250M | Jan 2020 |
| NNEAR | Unknown | $100M | Jan 2019 |
| XXMTP Labs | Series A | $20M | — |
| GGate Bio | Series B | $65M | — |
Top Co-Investors
Perceptive Advisors2 shared
Pura Vida Investments1 shared
DCVC1 shared
Roche Venture Fund1 shared
Cormorant Asset Management1 shared
Eventide Asset Management1 shared
T. Rowe Price1 shared
Section 321 shared
Sands Capital1 shared
Quest Diagnostics1 shared
Polaris Partners1 shared
ArrowMark Partners1 shared
Bain Capital Life Sciences1 shared
Squarepoint Capital1 shared
RA Capital Management1 shared
Forbion1 shared
GV1 shared
ARCH Venture Partners1 shared
Versant Ventures1 shared
Eli Lilly and Company1 shared
Last updated: 9 September 2026